Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
17 Results for "
NPC1L1
" in MedChemExpress (MCE) Product Catalog:
Products (17)
17 Results for "NPC1L1" in MCE Product Catalog:
16
Target:
Research Areas:
Ezetimibe (SCH 58235) is a potent cholesterol absorption inhibitor. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.
1
Target:
Cat. No.: HY-136059
CAS No.: 302781-98-2
Target:
Research Areas:
Desfluoro-ezetimibe is a desfluoro impurity of Ezetimibe. Ezetimibe is a potent, metabolically stable cholesterol absorption inhibitor. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator .
Cat. No.: HY-17376S1
CAS No.: 1093659-89-2
Synonyms: SCH 58235-d4-1
Cat. No.: HY-17376R
CAS No.: 163222-33-1
Synonyms: SCH 58235 (Standard)
Target:
Research Areas:
Ezetimibe (Standard) is the analytical standard of Ezetimibe. This product is intended for research and analytical applications. Ezetimibe (SCH 58235) is a potent cholesterol absorption inhibitor. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.
Cat. No.: HY-17376S
CAS No.: 1093659-90-5
Synonyms: SCH 58235-d4
Cat. No.: HY-17640
CAS No.: 1269181-69-2
Target:
Research Areas:
Nicodicosapent is a fatty acid niacin conjugate that is also an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metabolism proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1.
Cat. No.: HY-RS09475
Target:
Research Areas:
NPC1L1 Human Pre-designed siRNA Set A contains three designed siRNAs for NPC1L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS17515
Target:
Research Areas:
Npc1l1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Npc1l1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS23972
Target:
Research Areas:
Npc1l1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Npc1l1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P99362
CAS No.: 1092658-06-4
Synonyms: Anti-MUC5AC Reference Antibody (ensituximab); NEO-102
Cat. No.: HY-135388
CAS No.: 1376614-99-1
Synonyms: ent-SCH 58235
Target:
Research Areas:
ent-Ezetimibe (ent-SCH 58235) is the RRS-enantiomer of Ezetimibe. Ezetimibe is a potent cholesterol absorption inhibitor. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator .
Cat. No.: HY-17376S3
CAS No.: 438624-68-1
Synonyms: SCH 58235-13C6
Cat. No.: HY-N18304
CAS No.: 1162664-57-4
Target:
Cat. No.: HY-160882
CAS No.: 68207-16-9
EBOV-IN-7 (compound 26) is an inhibitor of the Ebola virus EBOV with an IC50 of 2.04 μM against EBOV-GP pseudotyped virus (pEBOV). EBOV-IN-7 has inhibitory effects on cancer cells and inhibits the EBOV-GPcl/NPC1 interaction .
Cat. No.: HY-121315
CAS No.: 1550053-19-4
Target:
Research Areas:
BRD4097 is an inhibitor of histone deacetylase (HDAC). BRD4097 acts by inhibiting the activity of HDACs, especially HDAC 1,2 and 3, through metal chelation and spatial rejection mechanisms, and this inhibition may help regulate gene expression and alter chromatin structure, thereby affecting a variety of biological processes. BRD4097 is used to study the role of HDAC in cholesterol metabolism and NPC1 diseases .
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
